C12Y 402/02007
Heparin lyase , i.e. heparinase i
Official title: Heparin lyase (4.2.2.7), i.e. heparinase I
C12Y402/02007 (Heparin lyase , i.e. heparinase i) appears on 6 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 8
- Assignees
- 8
- Inventors
- 32
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Application of microbial glycosidase as an anti-viral therapeutic, prognostic, and diagnostic26 May 2026US 12,636,353 B2The Regents of the University of California
- Heparinase-producing Pseudomonas stutzeri strain and heparinase derived therefrom26 Jan 2021US 10,900,028 B2Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Heparinases obtained from Sphingobacterium daejeonense, preparation therefor and application thereof26 Feb 2019US 10,214,735 B2Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Agents for the prevention and/or treatment of central nervous system damage13 Feb 2018US 9,889,150 B2The University Court of the University of Glasgow
- Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum6 Jul 1999US 5,919,693 AIbex Technologies Ltd.
- Application of microbial glycosidase as an anti-viral therapeutic, prognostic, and diagnostic7 Sep 2023US 2023/0277634 A1The Regents of the University of California
- Heparinase-producing Pseudomonas Stutzeri Strain and Heparinase Derived Therefrom23 Apr 2020US 2020/0123524 A1Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Sulfated heparin oligosaccharide and preparation method and application thereof3 Jan 2019US 2019/0002596 A1Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Heparinases obtained from sphingobacterium daejeonense, preparation therefor and application thereof22 Feb 2018US 2018/0051270 A1Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
- Compositions And Methods For Heparan Sulfate As A Biomarker For Transplant Rejection21 Apr 2016US 2016/0109459 A1Duke University
Most cited
By later US patents
- Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum23US 5,681,733 AIbex Technologies Ltd. · 1997
- Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum22US 5,919,693 AIbex Technologies Ltd. · 1999